The blockbuster weight loss drugs’ access to a key market — older Americans — is limited, as Medicare is banned from covering weight loss drugs as part of the Part D program.
© 2020-23 Digest Wire. All rights belong to their respective owners.
Tuesday, November 5, 2024
Ozempic, Wegovy-maker hires lobbying firm to push for Medicare coverage
ADVERTISEMENT
Trending
Expanded TCCF Market Opens With Talk of Money and Opportunity: ‘We Have Diversity and the Creative Freedom to Tell Those Stories’
Officials and filmmakers were on hand Tuesday in Taipei to hail the Taiwan Creative Content Fest as...
DigestWire is an automated news feed that utilizes AI technology to gather information from sources with varying perspectives. This allows users to gain a comprehensive understanding of different arguments and make informed decisions. DigestWire is dedicated to serving the public interest and upholding democratic values.
Privacy Policy Terms and Conditions